Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-10T16:08:24.788Z Has data issue: false hasContentIssue false

Effects of atropine on refractive development, dopamine release, and slow retinal potentials in the chick

Published online by Cambridge University Press:  01 March 2000

HARTMUT N. SCHWAHN
Affiliation:
Department of Experimental Ophthalmology, University Eye Hospital, Tübingen, Röntgenweg 11, D-72076 Tübingen, Germany
HAKAN KAYMAK
Affiliation:
Department of Experimental Ophthalmology, University Eye Hospital, Tübingen, Röntgenweg 11, D-72076 Tübingen, Germany
FRANK SCHAEFFEL
Affiliation:
Department of Experimental Ophthalmology, University Eye Hospital, Tübingen, Röntgenweg 11, D-72076 Tübingen, Germany

Abstract

Atropine has previously been found to suppress visually induced myopia both in animals and humans. The mechanism of its action is unclear. We have studied its retinal effects in an in vitro preparation, using the retina-pigment epithelium-choroid complex of the chick eye. In vivo, deprivation myopia was induced by translucent goggles. Atropine solution was injected into the vitreous at two-day intervals. Dopamine release from the retina following atropine injection in vivo and from the in vitro retina preparation was quantified by HPLC-EC. In vitro preparations of the isolated chick retina–pigment epithelium–choroid were superfused with atropine. Light-induced potentials (local ERG), slow standing potentials from the retinal pigment epithelium/neural retina, and extracellular potassium concentrations were recorded. In line with previous findings, intravitreal injections of atropine (25 μg, 250 μg) reduced deprivation myopia in a dose-dependent manner. Atropine increased the release of the neurotransmitter dopamine into the superfusate in vitro at 100–500 μM and into the vitreous in vivo at 250 μg. Before an increase was measured in the vitreous, the retinal dopamine content was elevated. In concentrations equivalent to the intravitreal concentration to suppress myopia in vivo (200–800 μM), atropine induced spreading depression (SD) in the in vitro preparation. In contrast, muscarinic agonists, acetylcholine and pilocarpine, did not induce SD. Atropine reduced the ERG b- and d-wave, led to damped oscillations of RPE potentials, and reversed the ERG c-wave. Atropine suppressed myopia only at doses at which severe nonspecific side effects were observed in the retina. Atropine seems to intrude massively into the vital functions of the retina as indicated by the occurrence of SD. We conclude that atropine, by inducing SD, boosts neurotransmitter release from cellular stores, which may cancel out a presumed retinal signal that controls eye growth and through this, myopia.

Type
Research Article
Copyright
2000 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)